TPOXX® Antiviral Treatment (Tecovirimat)
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security AgencycontractFind a Tender ↗Ref ocds-h6vhtk-037efd32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
1 SME
Lots
1
1 awarded
Published
03 Nov 2022
Description
The monkeypox virus belongs to a family of viruses called orthopox viruses and the drug Tecovirimat is an antiviral designed specifically to treat viral infections of this kind. In the current outbreak, Tecovirimat has been successfully used to treat patients with the most severe presentations of monkeypox virus infection. This contract is for a small supply of TPOXX® Antiviral Treatment (Tecovirimat) for the treatment of severe cases of Monkeypox in the UK.
Scope
- Reference
- C79951
- Commercial tool
- Standalone contract
- Main category
- goods
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Award procedure without prior publication of a call for competition
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to